The adoption of the FDA-approved Alzheimer's drug, Leqimbi, has slowed down in the U.S. as more experts grow hesitant about the drugs cost, risks and efficacy.
Amjevita leads Humira biosimilars in clinician comfort as rheumatologists remain wary healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
"Discover the latest trends in gastroenterology consolidation as management organizations and groups expand, and how private equity is playing a major role in d
Neurologists Report Frustration with Efficacy and Logistical Issues Around Eisai/Biogen's Leqembi, According to Spherix Global Insights Neurologist Survey streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Parkinson's Disease Patient Identification and Education Will Need to Improve When New Disease Modifying Therapies Are Approved, According to Spherix Global Insights streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.